This is a significant development that brings hope to the one billion individuals with obesity worldwide. Researchers led by Director C. Justin LEE from the Center for Cognition and Sociality (CCS) within the Institute for Basic Science (IBS) have discovered new insights into the regulation of fat metabolism.
Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar – Biotech Investments
EQS-News: Formycon AG / Key word(s): Agreement/Market Launch Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar 07.08.2023 / 08:00 CET/CEST The